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Abstract
Case-control studies have consistently associated psychological factors with chronic pain in
general and with temporomandibular disorders (TMD) specifically. However, only a handful of
prospective studies has explored whether pre-existing psychological characteristics represent risk
factors for first-onset TMD. The current findings derive from the prospective cohort study of the
Orofacial Pain Prospective Evaluation and Risk Assessment (OPPERA) cooperative agreement.
For this study, 3,263 TMD-free participants completed a battery of psychological instruments
assessing general psychological adjustment and personality, affective distress, psychosocial stress,
somatic symptoms, and pain coping and catastrophizing. Study participants were then followed
prospectively for an average of 2.8 years to ascertain cases of first-onset of TMD, and 2,737
provided follow-up data and were considered in the analyses of TMD onset. In bivariate and
demographically-adjusted analyses, several psychological variables predicted increased risk of
first-onset TMD, including reported somatic symptoms, psychosocial stress, and affective distress.
Principal component analysis of 26 psychological scores was used to identify latent constructs,
revealing four components: stress and negative affectivity, global psychological and somatic
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symptoms, passive pain coping, and active pain coping. In multivariable analyses, global
psychological and somatic symptoms emerged as the most robust risk factor for incident TMD.
These findings provide evidence that measures of psychological functioning can predict first-onset
of TMD. Future analyses in the OPPERA cohort will determine whether these psychological
factors interact with other variables to increase risk for TMD onset and persistence.
Keywords
temporomandibular disorders; psychological risk factors; chronic pain; somatic symptoms;
psychosocial stress
Introduction
The association of psychological factors with clinical pain has been well documented.
Numerous cross-sectional studies demonstrate that people with chronic pain conditions
show greater levels of psychological distress, environmental stress, catastrophizing, and
somatic symptoms compared with pain-free controls.19,34,42 Temporomandibular disorders
(TMD) represent a group of orofacial pain conditions that are highly prevalent in the
population and are associated with considerable morbidity.20,21,41 Similar to the above
findings, in other chronic pain conditions, people with chronic TMD pain exhibit greater
psychological maladjustment, on average, compared to healthy controls 23,73. For example,
in studies conducted in the U.S. and Europe, people with chronic TMD reported higher
mean levels of affective distress, somatic awareness, psychosocial stress, and pain
catastrophizing than pain-free individuals.11,30,54,57,70 In other cross-sectional studies,
personality characteristics, such as neuroticism, differed for chronic TMD cases versus
controls. 29,66 Related findings are that psychological dysfunction is associated with greater
severity and persistence of TMD-related clinical symptoms. For example, in cross-sectional
studies, scores on measures of psychological distress were positively correlated with
reported TMD pain and pain-related disability.9,57,90 Further, in studies involving patients
with existing TMD, psychological factors, such as somatic symptoms and depression,
predict long-term persistence of TMD pain.25,33,61
Because the preceding associations were observed in studies of people with existing TMD,
they do not establish whether psychological factors were premorbid risk factors for the
development of TMD. In a precursor to the present study, Slade and colleagues 81 showed
that several psychological factors associated with experimental pain sensitivity, including
depression, perceived stress, and mood state, predicted new onset TMD pain in a cohort of
females followed over a three-year period. Subsequently, Aggarwal et al2 reported that
baseline levels of health anxiety (i.e. concern regarding bodily symptoms), predicted risk for
development of chronic orofacial pain over the following two-year period. More recently,
depression and anxiety were found to predict new onset of TMD-related joint and muscle
pain, respectively 44. Thus, the limited available data from prospective studies implicate
psychological variables as potential etiologic risk factors for TMD.
The Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) prospective
cohort study endeavors to discover etiologic influences on TMD pain. While previous
research has identified multiple psychological variables that confer increased risk for
development of chronic pain, few studies have incorporated a broad-based assessment of
psychological functioning in order to identify risk factors for development of TMD. To
overcome this potential limitation, OPPERA administered an extensive battery of
psychological instruments to a cohort who did not have TMD when enrolled in the study.
The goal was to assess psychological functioning, prior to onset of TMD, across several
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domains that previously were associated with chronic pain, including TMD. We recently
reported psychological findings from the OPPERA baseline case-control study, in which a
cohort of participants meeting diagnostic criteria for chronic TMD were compared to a
control cohort comprised of individuals who did not have TMD.30,78 Chronic TMD cases
reported higher levels of psychological symptoms, affective distress, somatic symptoms, and
pain catastrophizing compared to TMD-free controls.
Below we present findings from the OPPERA prospective cohort study in which people who
initially were found not to have TMD when examined were followed for up to 5.2 years in
order to detect first-onset TMD. The primary aim of this study was to identify psychological
characteristics at enrollment that were associated with development of first-onset TMD. A
secondary aim of the study was to explore the extent to which psychological variables
interact with demographic factors as well as with other psychological variables in predicting
risk for TMD onset.
Materials and Methods
Institutional review boards at each study site approved study procedures and participants
provided signed, informed consent. Full details of enrollment, follow-up and statistical
analyses are provided elsewhere in this volume79 and are summarized here.
Recruitment, Eligibility Criteria and Enrollment
This paper reports findings from the OPPERA prospective cohort study of 2,737 people who
were enrolled in 2006–08 and followed for up to 5.2 years in order to identify those who
developed temporomandibular disorder (TMD). OPPERA used advertisements, emails,
flyers and word-of-mouth to recruit participants between May 2006 and November 2008
from communities in and around academic health centers at four US study sites: Baltimore,
MD; Buffalo, NY; Chapel Hill, NC; and Gainesville, FL. When they were enrolled, the
sample of community-based volunteers at four study U.S. sites was aged 18–44 years and
did not have painful TMD when examined using Research Diagnostic Criteria for TMD
(RDC/TMD).21 The average age of the sample was 27.1 years (SD=7.8), and the sample was
comprised of 1630 women (59.6%) and 1448 non-Hispanic whites (52.9%), 766 African
Americans (28%), and 523 (19.1%) participants from other ethnic/racial groups. At
enrollment, study participants also completed questionnaires, autonomic function and
sensitivity to sensory stimuli were evaluated, and a blood sample was collected for
genotyping. This paper focuses on contributions of baseline measurements of psychological
functioning (i.e., those recorded at enrollment) to subsequent risk of developing TMD.
Additional methodological detail is available elsewhere in this volume.79
Psychological Instruments
In order to strike a balance between thoroughness and participant burden, the selection of
psychological instruments for the OPPERA Study was based on the following criteria: 1) we
emphasized constructs identified in the previously proposed OPPERA heuristic model,
including mood/affect, stress, somatic symptoms16,56 ; 2) we prioritized constructs
previously associated with TMD in either case-control or prospective studies; and 3) we
endeavored to include constructs assessing both general psychological function (e.g.
personality, psychological symptoms) and more specific pain-related constructs (e.g. pain
coping, somatic symptoms). The psychological questionnaires administered are described
below. For all instruments, participants had the option to complete the questionnaire via
paper form or electronic PDF version. Through self-selection, slightly more than one-third
of participants (ranged from 36.2% to 39.5% depending on the questionnaire) completed the
instruments via paper and just under two-thirds completed them electronically, and mode of
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administration had minimal effect on any of the reported outcomes. To distribute participant
burden, most of the questionnaires were completed before the baseline clinic visit (pre-
clinic), while state-based measures (the State Anxiety Inventory and the Profile of Mood
States-Bipolar) were completed in-clinic immediately before the baseline clinical
examination. Missing questionnaire items were imputed using the expectation-maximization
(EM) algorithm as described previously.30 In general, if a subject skipped at least one but
less than half the items in a questionnaire, the missing items were imputed. If they failed to
complete at least half of the items in the questionnaire, we treated their summary score as
missing.
Global Measures of Psychological Function
Symptom Checklist 90-Revised (SCL90R)—This 90-item instrument evaluates a
broad range of psychological symptoms by having participants report the extent to which
they have been bothered by each symptom on a five-category scale (not at all, a little bit,
moderately, quite a bit, extremely). The SCL90R provides measures of psychological
distress across the following nine subscales: Somatization, Obsessive-Compulsive,
Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation,
and Psychoticism.16 Some evidence suggests a unitary factor structure for the SCL90R, 24,
while other findings indicate a multiple factor structure, overlapping to some extent with the
subscales originally reported by Derogatis.65,77 Given this mixed evidence and consistent
with the preponderance of studies using this instrument to investigate chronic pain, we chose
to use the original scoring to optimize comparisons with existing literature. This instrument
has demonstrated good internal consistency (Cronbach’s alpha for subscales in our sample
ranged from 0.78 to 0.88) and test-retest reliability, which ranged from 0.78 to 0.90.15 The
SCL90R has been widely used in research with numerous pain conditions,3,13,67,69,76
including TMD.43,48,63,87
Eysenck Personality Questionnaire-Revised (Short Form, EPQ-R)—This 57-item
true-false instrument assesses three personality dimensions: Extraversion, Neuroticism, and
Psychoticism. The EPQ-R also includes a Lie scale, which reflects an effort to present
oneself in the most positive light. Factor analysis of the EPQ-R supports the four scales, and
internal consistency of each of the scales is acceptable, with Cronbach’s alpha in our sample
ranging from 0.62 to 0.82, similar to that previously reported for the full scale.28 Scales
derived from the 57-item EPQ-R Short Form were found to correlate highly with scale
scores from the original EPQ-R, with correlation coefficients ranging from 0.89 to 0.96 27.
Based on previous research in chronic pain populations,7,14,38,85 including TMD,45,46 our
analyses focused on the Extraversion and Neuroticism scales.
Measures of Affective Distress
State-Trait Anxiety Inventory (STAI)—The STAI includes two 20 item questionnaires,
the State Anxiety Inventory and the Trait Anxiety Inventory.82 For each item, participants
are asked to indicate either how they “generally feel” (trait anxiety) or how they “feel right
now” (state anxiety) using a four-category scale (not at all, somewhat, moderately so,
extremely so). Test-retest reliability for the Trait Anxiety Scale has been adequate, ranging
from 0.73 to 0.86 over intervals of 20 to 104 days.82 As expected, State Anxiety is
significantly less stable over time, given the transitory nature of anxiety states. In our
sample, internal consistencies for both scales were high, with Cronbach’s alphas of greater
than 0.91.
The Profile of Mood States-Bipolar (POMS-Bi)—This instrument consists of 72
mood-related items, and participants indicate the extent to which each item describes their
mood state over the past week, including today, using a four-category scale (much unlike
Fillingim et al. Page 4













this, slightly unlike this, slightly like this, much like this). This questionnaire assesses both
positive and negative affective dimensions. It yields six subscale scores (Agreeable-Hostile,
Elated-Depressed, Confident-Unsure, Energetic-Tired, Clearheaded-Confused, Composed-
Anxious), as well as global indices of Positive Affect and Negative Affect, which were the
focus of our analyses. Internal consistency in our sample was high for both Positive Affect
(0.91) and Negative Affect (0.94). The POMS has been well validated with other mood
measures and is sensitive to subtle differences in affective state.53
Measures of Psychosocial Stress
The Perceived Stress Scale (PSS)—This 10-item scale assesses the perception of
stress, that is, the degree to which an individual appraises situations as stressful, and the
extent to which an individual perceives themselves capable of coping with the situations 12.
For each item, participants indicate how often they felt or thought that way in the past month
using a five-category scale (never, almost never, sometimes, fairly often, very often). The
PSS yields a single overall perceived stress score by summing the numerical weights of each
item, after reverse scoring four of the items. Internal consistency was good with Cronbach’s
alpha of 0.86 in our sample, and construct validity has been demonstrated, as the PSS
correlates significantly with other measures of stress appraisal.12
The Life Experiences Survey (LES)—This 57-item instrument assesses the frequency
of life events that have occurred over the past year, as well as the impact of these events 75.
Impact ratings range from −3 (extremely negative) to +3 (extremely positive), with 0
indicating “no impact.” There are multiple approaches to scoring the LES, which generally
yield measures of frequency of positive, negative, and total events as well as positive,
negative, and total impact of events. The test-retest reliability of positive impact was
reported as low (0.10 and 0.53 across two samples), while reliabilities for negative and total
impact were adequate, ranging from 0.56 to 0.88. Therefore, we report the number and
impact of negative events. Cronbach’s alpha for the number of negative events in our sample
was 0.93. Previous research indicated that scoring of impact based on individualized weights
(i.e., each respondent’s rating of impact) was the best predictor of psychological distress91;
therefore, we report negative impact scores based on individualized weights in the included
tables. For the LES, subjects who endorsed 40 or more items were excluded, on the grounds
that they likely misunderstood the instructions for the questionnaire. Others were excluded
from LES scoring if their answers were inappropriate based on their gender. (For example,
male respondents who reported a pregnancy in the previous year were discarded.)
The Lifetime Stressor List/PTSD Checklist-Civilian Version (LSL/PCL-C)—The
LSL presents a checklist of 15 different traumatic events, and participants indicate which (if
any) of these events they have experienced. For participants who endorse at least one item,
they are then asked to identify the most significant stressor, and they complete the remaining
17-items regarding the extent to which they experience PTSD symptoms (e.g., repeated,
disturbing memories of the experience) related to the selected traumatic event. Each item is
endorsed on a five-category scale (not at all, a little bit, moderately, quite a bit, extremely).
A total score is derived by summing the scores from each of the 17 symptoms. Test-retest
reliability is high (0.96), and internal consistency has ranged from 0.89 to 0.92.88 Internal
consistency in our sample was 0.93. For participants who did not endorse any traumatic
events, PCL-C scores were set to a minimum score of 17.
Measures of Somatic Symptoms and Reactivity
People with chronic pain often report multiple somatic symptoms across different bodily
systems (e.g. nausea, fatigue, dizziness), and varied terminology has been applied to this
phenotypic domain, including somatization, hypochondriasis, hypervigilance, and somatic
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awareness.30,31,59 These terms imply underlying cognitive or psychological processes that
are not directly assessed in most instruments. Therefore, we use the term “somatic
symptoms,” which we believe accurately reflects the construct assessed by the two primary
measures included in the OPPERA study, the PILL (described below) and the SCL90R
Somatization Scale (described above).
The Pennebaker Inventory of Limbic Languidness (PILL) assesses the frequency with which
individuals experience of 54 common physical symptoms and sensations on a five-category
scale (never or almost never, less than 3 or 4 times a year, every month or so, every week or
so, more than once every week). A single summary score is derived by summing each of the
individual item responses, and PILL scores are related to the construct of somatic awareness
or the general tendency to endorse physical symptoms. High internal consistency (alpha =
0.88) and adequate test-retest reliability (0.70 over two months)68 have been reported.
Internal consistency in our sample was 0.93. The PILL has been used as a measure of
general somatic symptomatology in fibromyalgia patients, who demonstrated higher scores
on the PILL compared to arthritis patients and pain-free controls.59
The Kohn Reactivity Scale47—This instrument consists of 24 items that assess an
individual’s level of reactivity or central nervous system arousability to sensory stimuli.
Individuals respond to each item on a five-category scale ranging from “disagree strongly”
to “agree strongly.” The Kohn yields a single summary score created by summing all of the
items, after reverse scoring half of the items. This measure has been reported to have
adequate internal consistency, ranging from alpha of 0.73 to 0.83 in previous studies47 and
0.81 in our sample. The Kohn has been shown to correlate negatively with pain tolerance 17
and it has been used as a measure of the construct of hypervigilance.59
Measures of Coping/Catastrophizing
The Coping Strategies Questionnaire-Revised (CSQ-R)—The CSQ-R is a revised
version of the original CSQ,74 consisting of 27 items relating to how individuals cope with
pain. Participants indicate the frequency with which they engage in specific coping activities
when experiencing pain using a seven-category numerical scale, ranging from 0 (never do
that) to 6 (always do that). It yields six subscales reflecting the pain coping strategies that
individuals use: diverting attention, catastrophizing, praying and hoping, ignoring pain
sensations, reinterpreting pain sensations, and coping self-statements. The subscales showed
adequate internal consistency, with Cronbach’s alpha ranging from 0.82 to 0.92 in our
sample. The CSQ-R has been shown to have stable factor structure in people with chronic
pain 72 and in healthy populations.36 Because the catastrophizing scale from the CSQ-R is
identical to the Helplessness scale from the PCS (see below), the CSQ-R’s catastrophizing
scale was excluded from all analyses.
The Pain Catastrophizing Scale (PCS)—This instrument consists of 13 items rated on
a 5-point scale ranging from 0 (not at all) to 4 (all the time). Participants indicate the degree
to which they have specified thoughts and feelings when experiencing pain. The measure
assesses three dimensions of catastrophizing: Rumination, Magnification, and Helplessness,
and a total score is calculated by summing the three subscales. Internal consistency was very
good, with coefficient alphas ranging from 0.74 to 0.91 across subscales in the current
sample. The PCS has been validated for both clinical and nonclinical samples.64,84 For
nonclinical samples, respondents are asked to respond to the questionnaire based on their
thoughts when they experience common pain events (e.g. headache, toothache).
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Follow-up and Case-Classification of First-Onset TMD
At three-monthly intervals after enrollment, study participants were asked to complete
questionnaires that screened for TMD pain symptoms. Specifically, participants responded
to questions about "headaches or pain in your face, jaw, temples, in front of the ear, or in the
ear” (hereafter "orofacial pain") during the reporting period. Those reporting symptoms were
contacted by the study site by telephone and/or email and asked to return for an examination
that determined presence or absence painful TMD using the same RDC/TMD criteria.
Specifically, to be classified as incident cases, study participants had to meet two criteria:
(1) symptoms of orofacial pain reported for ≥5 days in the prior 30 days; and (2) examiner
findings of TMD myalgia, arthralgia, or both. Of the 3,263 participants enrolled into the
inception cohort, 2,737 (84%) completed one or more quarterly follow-up questionnaires,
with a median of 10 follow-up questionnaires over a median 2.8 follow-up year period.
Additional details regarding follow-up rates are provided in Bair, et al.5
Statistical Analysis
A multi-stage analytic approach was developed to identify psychological characteristics that
predicted TMD onset and to determine which psychological variables interacted with
demographic factors and with other psychological variables in predicting risk for TMD
onset. As is common in epidemiologic studies of TMD 1,46, the first stage of analysis
examined univariate associations to test which individual psychological variables predicted
TMD onset. This univariate approach provides information regarding which individual
psychological measures are associated with risk for development of TMD and provides a
basis for readers to compare findings across studies using the same variable. The limitation
of this approach is that, not surprisingly, some of the individual variables are intercorrelated,
and findings from the univariate approach should be interpreted with the knowledge that
some of the associations are not independent.
The second stage of the analysis involved a series of multivariable Cox regression models in
which the entered psychological variables were derived from a principal component analysis
(PCA), which was performed in order to reduce the number of psychological variables by
identifying putative latent constructs. The goal of Cox multivariable modeling was to assess
independent contributions of each latent construct to TMD incidence. In this context, an
"independent" contribution is one which is not confounded by the other latent constructs.
Hazard ratios for the associations were estimated in a single Cox regression model that
included all latent constructs as predictor variables, together with study site and socio-
demographic characteristics. First, all factors were entered into a multivariable Cox
regression model simultaneously in order to identify the factors that independently predicted
development of TMD. Second, interactions of each factor score with demographic variables
in predicting TMD development were examined in Cox regression models. Third, all
possible two-way interactions between factor scores were examined in regression models.
This more traditional multivariable approach allowed us to examine whether psychological
variables, either alone or via interactions with other variables, predicted TMD onset.
The third stage of the analysis involved a different multivariable approach, random forest
modeling, to analyze potential contributions of all measured psychological variables, not
merely the reduced set of latent constructs. This novel method of data mining was used to
achieve two goals: a) to identify the most important risk factors for first-onset TMD; and b)
to generate plots depicting adjusted association between each variable and TMD incidence,
with adjustment for the effects of other variables and with latitude in generating the plots
that permitted departure from a straight-line association. Random forest modeling represents
a machine learning technique based on a series of decision tree models.40 Decision trees
predict outcomes by recursively partitioning predictor variables, and these trees are superior
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to regression-based models in identifying non-linear effects and handling missing data.
Random forests improve the accuracy of individual decision trees by averaging over a series
of decision trees. In recent years, random forests have been increasingly applied to
classification problems in biomedical research, including predicting several pain related
outcomes.39,71,89 The random forest model computed importance scores for each variable,
representing the decrease in the predictive accuracy of the model when the variable is
removed from the analysis. The most important variable was assigned a score of 100, and all
other importance scores have lower values that could range to a negative value if the
variable worsened prediction. The random forest model was used also to compute the
expected rate of first-onset TMD that would be observed at several values of the variable
after averaging over the values of all other variables in the model. Partial dependence plots
were then generated and LOESS smoothing was used to help visualize the association.52
The two multivariable strategies were selected in favor of other approaches for several
reasons. The first strategy builds on findings from our baseline case-control studies which
identified meaningful latent constructs from among the multitude of psychological measures
used in OPPERA.30 The relatively small number of latent constructs meant that all four of
them could be used in a single Cox regression model, thereby adjusting for potential
confounding effects between constructs. This avoided arbitrary choices and potential bias
that occur commonly when stepwise procedures and related variable selection methods are
used to select a restricted set of potential confounders.35 However, regression using
principal component scores can mask effects on TMD incidence of single items that do not
fit will within the latent constructs. Furthermore, it does not provide information about the
relative importance of the variables that contribute to each score, and variable selection
methods used to exclude variables from a large candidate set of predictors do not provide
information about the excluded variables. Also, variable selection regression methods
produce p-values and confidence intervals that are unreliable.1,35 Thus, a random forest
model was used to address these shortcomings.8,40 Random forests have other advantages
compared to conventional linear regression models. For example, random forests can impute
for missing data and handle large numbers of correlated predictor variables without
decreasing the accuracy of the model.37
For descriptive purposes, the rate of first-onset TMD was calculated as the number of people
with first-onset TMD divided by the sum of follow-up periods, and the result was expressed
as the percent of people per annum. To test hypotheses about associations between baseline
characteristics and the TMD incidence rate, univariate hazard ratios were first computed
using Cox proportional hazard regression. For each variable, scores were transformed to
unit-normal deviates (mean=0, standard deviation=1), which allows hazard ratios to be
compared meaningfully when original psychological scores were computed using different
scales. Hazard ratios were computed with adjustment for study site and with additional
adjustment for age, gender, race/ethnicity and lifetime US residence. Univariate hazard
ratios were also computed using multiple imputation to assess two sources of potential
biases associated: a) non-examination of 243 people with symptoms (due to their
unwillingness or inability to return to the study site for re-examination, see Bair, et al 5 for
further detail); and b) a higher-than expected rate of TMD classification for one examiner
who conducted 75 examinations. Additional details regarding the multiple imputation
approach are provided in Bair et al.5 Briefly, the multiple imputation procedure used logistic
regression to estimate the probability of examiner-verified TMD for all symptomatic
episodes that were followed by an examination, excluding examinations conducted by the
examiner in question. The parameters from this regression were then applied to symptomatic
episodes that were not followed by an examination and to all episodes that were classified
by the examiner in question, yielding a predicted probability of first onset TMD for such
episodes.
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The variables included in the PCA were selected based on both our previous case-control
findings and the OPPERA conceptual model.30 For purposes of predicting first-onset TMD,
we expanded the variables included in the PCA model in order to insure that all important
predictors were represented. All variables in Table 1 were included in the PCA, except for
the two LES variables, which were excluded due to high rates of missingness. Consistent
with our previous approach30, PCA models were fit using the R statistical computing
platform. All variables were normalized to have mean 0 and standard deviation 1 prior to
fitting the models. Eigenvalues from the initial, unrotated solution were inspected using a
scree plot. To help determine the optimal number of eigenvectors, a parallel analysis was
performed to determine the number of components that exceeded what would be expected
due to chance alone. Parallel analysis estimates the number of components to include in a
PCA model by generating random data sets with the same numbers of observations and
predictor variables as the original data.86 The eigenvalues are computed for each random
data set and averaged over all the data sets. When the average eigenvalue from these
randomly generated data sets is larger than the corresponding eigenvalue of the original
data, then the principal component associated with that eigenvalue is likely to be random
noise (see Supplementary e-Figure 1). After calculating the PCA eigenvectors, a promax
rotation was applied to increase the interpretability of the resulting PCA loadings. The
promax rotation produced loadings that were easier to interpret than the loadings resulting
from orthogonal rotations, and other non-orthogonal rotations produced similar results. The
rotated loadings are presented unless otherwise noted.
Results
During the follow-up period, 721 orofacial symptom episodes were reported, 478 (66%) of
which resulted in RDC examinations. These examinations classified 235 participants as
TMD onset cases. In addition, 338 participants who did not report orofacial symptom
episodes were selected at random for examination, and 25 of these examinations (7%) were
classified with TMD onset. Thus, a total of 260 examiner-verified cases of TMD onset were
ascertained (see Bair et al. 5 for further detail).
Univariate Findings
Measures of Global Psychological and Somatic Function, Stress and Mood
(see Table 1)—Among the psychological characteristics reported in Table 1, the highest
hazard ratio (HR) for predicting TMD onset emerged for the PILL (imputed HR=1.55), a
measure of somatic symptoms. The effect was statistically significant, as demonstrated by
the associated 95% confidence interval (1.33 to 1.66) that excluded the null of one. Also,
greater scores on all SCL90R subscales were associated with increased incidence of TMD,
with hazard ratios ranging from 1.22 (for the Phobia and Paranoid scales) to 1.44 for the
Somatization scale. For both the PILL and SCL90R scales, the rate of TMD was highest for
people in the upper tercile of the scales' distributions, whereas the lower- and mid-terciles
differed to a smaller degree.
A greater degree of PTSD symptoms, as measured by the PTSD Checklist for Civilians, was
associated with statistically-significantly greater TMD incidence (HR=1.38). Regarding
personality as measured by the EPQ-R, neuroticism was associated with increased rates of
TMD onset, with a hazard ratio of 1.28, while extraversion was not associated with
statistically significant variation in TMD incidence. Higher scores on the Perceived Stress
Scale predicted increased incidence of TMD (HR=1.34), and a greater number (HR=1.30)
and impact (HR=1.27) of negative events reported on the Life Experiences Survey predicted
increased rates of TMD onset. Both trait and state anxiety were associated with increased
incidence of TMD, with hazard ratios of 1.4 and 1.22, respectively. Negative affect
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(HR=1.24) and positive affect (HR=0.8), measured with the POMS-Bi, were associated with
increased and decreased rates of TMD onset, respectively. Across most measures, hazard
ratios and their 95% confidence intervals were only slightly lower when using imputed
versus non-imputed data.
Measures of Active and Passive Coping and Reactivity (see Table 1)—None of
the subscales of the Pain Catastrophizing Scale (Rumination, Magnification, Helplessness)
predicted TMD onset to a statistically significant degree, although the Helplessness scale
was weakly significant when using imputed data (HR=1.12). Likewise, no subscales from
the Coping Strategies Questionnaire were statistically significant predictors of TMD
incidence. The Kohn Reactivity Scale also was not a significant predictor of TMD onset.
Principal Component Analysis (PCA)
As in our original PCA 30, a four-component solution emerged based on the scree plot and
parallel analysis (See Supplementary e-Figure 1). The loadings for the PCA model are
shown in Table 2. The four components, which are consistent with our previous PCA, are
labeled: 1) Global Psychological and Somatic Symptoms (high loadings from all SCL-90-R
scales, the PILL, and the LSL/PCL-C PTSD symptom scale); 2) Stress and Negative
Affectivity (high loadings from both State and Trait Anxiety, Perceived Stress, POMS
Negative Affect, and EPQ-R Neuroticism; negative loadings for POMS Positive Affect and
EPQ-R Extraversion); 3) Passive Pain Coping (positive loading from all three PCS
subscales, the Praying and Hoping subscale of the CSQ-R, and the Kohn score); 4) Active
Pain Coping (positive loadings from the remaining CSQ-R subscales). These four
components were used in further univariate and multivariable analyses presented below.
Univariate Analyses of PCA Components as Predictors of First-Onset TMD—
In univariate analyses of single PCA scores, high levels of Global Psychological and
Somatic Symptoms (imputed HR=1.37) and Stress and Negative Affectivity (imputed
HR=1.31) predicted increased TMD incidence in both the unimputed and imputed analyses
while Passive Pain Coping was a weaker, though statistically significant, predictor of TMD
incidence (imputed HR=1.16, see Supplementary e-Table 1 for detailed information).
Table 3 presents the outcomes of analyses examining PCA components as predictors of
TMD onset, stratified separately by age, gender, and race/ethnicity. In general, PCA
components did not interact with demographic factors in predicting TMD onset, such that
hazard ratios were similar across age groups, gender and race/ethnicity. However, Global
Psychological and Somatic Symptoms was the exception, showing a modest interaction with
age group (p=0.03), such that this component was a stronger predictor of TMD incidence in
the two younger age groups compared to the 35–44 year old group.
Multivariable Analyses of PCA Components as Predictors of First-Onset TMD
—In fully-adjusted models (i.e., including study site and demographic factors) that
examined main effects of multiple PCA components predicting TMD incidence after
controlling for the other components, Global Psychological and Somatic Symptoms
remained the only strong predictor (imputed HR=1.33 , Table 4). The Stress and Negative
Affectivity component was a weakly significant predictor in the unimputed analysis, but did
not significantly predict TMD onset in the analysis using imputed data (HR=1.12).
The next multivariable analyses examined the two-way interactions among PCA
components. The findings indicated that Global Psychological and Somatic Symptoms
interacted with each of the other components in predicting TMD onset (all p’s < 0.01). The
pattern of findings was similar for all factors. Specifically, when Psychological and Somatic
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Symptom scores were low, the other components significantly predicted TMD onset. This
pattern of results is depicted for Global Psychological and Somatic Symptoms and Stress
and Negative Affectivity. After controlling for study site and demographic factors, the two-
way interaction was statistically significant (p=0.004, see imputed model in Supplementary
e-Table 2). As shown in Figure 1, the interaction indicated that Stress and Negative
Affectivity significantly predicted TMD onset when Global Psychological and Somatic
Symptoms were low (HR for Stress and Negative Affectivity = 1.30), but not when Global
Psychological and Somatic Symptoms were moderate or high (HR for Stress and Negative
Affectivity = 0.96).
Using the second multivariable approach of random forest models, the PILL emerged as the
most important predictor of TMD incidence, based on its variable importance score (VIS) of
100. The second most important predictor, the Perceived Stress Scale, contributed much less
to the predictive accuracy of the model (VIS=14.3), as did the SCL90R Anxiety (VIS=8.9)
and Obsessive-Compulsive (VIS=7.5) scores, the CSQ Ignoring Pain score (VIS=5.2), the
State Anxiety Inventory (VIS=5.0), the SCL90R Somatization Scale (VIS=4.8), and the LES
Sum of Negative Events score (VIS=3.1).
Three partial dependence plots from the random forest model were selected to illustrate
effects from different constructs showing relatively high variable importance scores (see
Figure 2). These variables were chosen for presentation from among the variables with the
highest variable importance scores to illustrate different non-linear patterns and to present
examples of findings from multiple psychological domains. Different ranges for the y-axis
scales were used to illustrate the full degree of variation in TMD incidence across variables
that differed in importance. For PILL scores, the predicted TMD incidence remained at a
constant low level below a score of approximately 95, at which time there was a linear
increase in risk up to a score of approximately 140, at which time further increases in PILL
scores did not confer additional risk. In contrast, for Perceived Stress Scores, a slight u-
shaped function emerged, such that risk of TMD onset was slightly higher at a score of zero
than at a score of 15, above which, risk of TMD onset increased in linear fashion through the
remainder of the scale range. For the CSQ Ignoring Pain Sensations scale, TMD incidence
was greatest at a score of 0 and decreased in linear fashion until a score of approximately
two, beyond which incidence increased slightly.
Discussion
These findings identify several psychological variables that represent premorbid risk factors
for first onset of TMD. Based on univariate analyses, psychological variables that predicted
TMD incidence include measures of somatic symptoms, general psychological symptoms,
negative mood, and multiple measures of stress, including PTSD symptoms, perceived
stress, and recalled life events. Measures of catastrophizing and active pain coping, well-
established constructs associated with chronic pain, were not significant predictors of TMD
first-onset. The largest hazard ratios emerged for measures of somatic symptoms. These
findings are consistent with the recently reported outcomes from our OPPERA case-control
study, in which measures of somatic symptoms were the psychological variables that
differed most markedly between TMD cases and TMD-free controls30, while measures of
negative mood and stress showed more modest, albeit significant, associations with chronic
TMD in that study. The generally consistent findings of the prospective and case-control
studies are notable, because the designs differ in at least two important dimensions. First, the
case-control study recruited chronic TMD cases, while the first-onset TMD cases captured
by the prospective study exhibit more acute symptoms by definition. The findings of
generally similar psychological risk factors for chronic TMD and first-onset, typically acute
TMD, suggest that these psychological factors are associated with both onset and chronicity
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of TMD. Second, the case-control study ascertained case status and psychological function
concurrently, while in the prospective study psychological assessment was completed
months or years before case classification. This implies that the influence of these
psychological factors extends over a long time period.
The prospective nature of the OPPERA study identifies these psychological factors as
predisposing risk factors for the development of TMD pain. Few previous studies
investigating psychological factors related to TMD have employed a prospective design.
Members of this research group reported that premorbid measures of depression, perceived
stress, and mood state obtained at baseline were significant predictors of new onset TMD in
a sample of healthy young females.81 Also, Aggarwal and colleagues2 showed that health
anxiety predicted future development of chronic orofacial pain in adults, and depression,
somatization and life satisfaction predicted TMD onset in adolescents.18,49 Additional
studies implicate psychological variables as premorbid risk factors for development of for
other chronic pain conditions, including chronic widespread pain 58, regional
musculoskeletal pain60, and low back pain.50,51,60
As in our previous report 30, PCA revealed that our psychological instruments assessed four
psychological domains, Global Psychological and Somatic Symptoms, Stress and Negative
Affectivity, Passive Coping, and Active Coping. Not surprisingly, the Global Psychological
and Somatic Symptoms component, on which measures of somatic symptoms loaded, was
the strongest predictor of TMD onset. In univariate analyses, Stress and Negative Affectivity
also predicted incident TMD; however, this association became weak or non-significant in
multivariable analyses that adjusted for the other principal components. Interestingly, in
individuals with moderate to high Global Psychological and Somatic Symptoms, Stress and
Negative Affectivity did not significantly predict TMD onset; however, when Global
Psychological and Somatic Symptoms were low, Stress and Negative Affectivity
significantly predicted TMD incidence. This suggests that Stress and Negative Affectivity
does not additively contribute to TMD risk over and above Global Psychological and
Somatic Symptoms, rather in the absence of global symptomatology, stress/negative affect
emerges as a potentially important risk factor. This interaction was modest in magnitude and
should be interpreted cautiously; however, based on these results, future studies designed to
examine psychological risk factors for TMD may benefit from assessing both of these
domains.
Passive Pain Coping failed to predict first-onset TMD in our prospective study, which
contrasts with previous case-control findings reported from the OPPERA Study 30;
additionally, other studies indicated higher levels of pain catastrophizing, a component of
passive pain coping, among people with TMD.10,70 However, that passive pain coping failed
to predict first-onset of TMD pain is not particularly surprising given the method of
assessment of this construct. In assessing catastrophizing, for example, individuals with pain
are asked to report how they respond to their existing pain condition. However, TMD-free
individuals, such as the participants at enrollment in our prospective cohort, were asked to
indicate how they respond to pain in general when it does occur, which represents a more
hypothetical construct. Indeed, in pain-free adults, such measures of general catastrophizing
have not consistently predicted responses to experimental pain, while post hoc assessments
of individuals’ catastrophic cognitions when they were experiencing experimental pain have
been associated with laboratory pain responses10,22. Thus, measures of catastrophizing, and
perhaps other forms of pain coping, may be associated with pain in a context-dependent
manner. In addition, catastrophizing may increase risk for transition from acute to chronic
pain rather than predicting pain onset.
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Analyses stratified by demographic factors revealed that psychological risk factors for first-
onset TMD were generally similar across age, sex, and racial and ethnic groups. One
exception was that Global Psychological and Somatic Symptoms predicted TMD incidence
more strongly in the two younger age groups (18–24, 25–34 years) versus the older age
group (35–44 years). Interestingly, this older group had the highest incidence of first-onset
TMD (see 79), and the present findings suggest that either unmeasured psychological
variables or non-psychological factors confer this increased risk of TMD onset in this age
group. However, it should be noted that the interaction of age with Global Psychological and
Somatic Symptoms in predicting TMD onset, though statistically significant, was modest in
magnitude and needs to be replicated.
In addition to more traditional regression-based multivariable analyses using the PCA factor
scores, random forest models provided an additional, more exploratory multivariable
approach that was able to accommodate the individual variables. The random forest models
identified similar predictors of TMD onset as observed in the univariate analyses, with the
PILL being the strongest predictor of TMD onset. Other variables with non-zero variable
importance scores, suggesting at least modest predictive ability even after accounting for
somatic symptoms, included the Perceived Stress Scale, State Anxiety, the SCL90R anxiety,
somatization, and obsessive-compulsive scales, and the CSQ Ignoring Pain Sensations
Scale. This latter scale did not emerge as a predictor in the univariate model, suggesting that
this coping strategy may provide some predictive value after adjusting for the effects of
other psychological variables. The depicted partial dependence plots indicate that the
association of a given predictor with TMD onset can be non-linear, and the pattern varies
across variables. For the three plotted variables, the non-linear patterns generally were
consistent with incidence rates reported for terciles of those variables in the univariate
analysis. Given that the multivariable regression used factor scores and the random forest
used individual measures, direct comparisons are not possible. However, in univariate
analyses as well as both multivariable approaches the somatic symptom construct
represented the strongest predictor of TMD onset, suggesting convergence of findings
regarding somatic symptoms across analytic methods.
While multiple psychological measures predicted TMD onset in univariate analyses, results
of multivariable models provide strong evidence that reported somatic symptoms represents
the strongest predictor of incident TMD in this analysis. Increased somatic symptom
reporting could result from altered physiological function leading to increased symptoms
and/or from altered central nervous system function resulting in greater awareness of
somatic and interoceptive cues. The mechanisms whereby somatic symptoms increase risk
for TMD remain unknown. Perhaps somatic symptoms may reflect or be associated with
health behaviors or conditions that increase risk of TMD. For example, somatic symptoms
could result from parafunctional behaviors (e.g. bruxism, nail-biting), or other behavioral
changes (e.g. sleep disturbance), which could in turn increase risk for TMD.62 Alternatively,
somatic symptoms may reflect underlying physiological perturbations, and these
physiological perturbations might contribute directly to the pathogenesis of TMD. Indeed,
enhanced responses in immune and inflammatory systems have been associated with
somatic symptoms4,26,55, and these biological pathways have also been implicated in TMD
in cross-sectional studies.80 Similarly, brain imaging findings suggest that overlapping
neural alterations may contribute to somatization and chronic pain states.32,83 Hence, it
seems plausible that in our cohort, high somatic symptom reporting at baseline could reflect
alterations in biological pathways that may increase risk for TMD onset. In any event,
increased reporting of somatic symptoms represents a strong risk factor for development of
TMD, and additional investigation of this construct is warranted.
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The findings of this study should be interpreted in light of its limitations. First, some
variables identified as significant risk factors in univariate analyses would not remain
significant in a related multivariable analysis (e.g., the PILL score and the SCL90R
Somatization score likely share predictive variance). This is supported by findings that both
measures load onto a single principal component and by results from random forest models
showing that the variable importance ranking of the SCL90R Somatization score was
considerably lower in the random forest model than in the univariate analysis. Second, while
we examined some of the potential interactions among factors (e.g. demographic measures
and PCA components), many other possible interactions were not tested (e.g. between
individual psychological measures) due to the exceedingly large number of statistical tests
this would require, and we chose to remain conservative in our explorations. Third, the
analyses herein do not examine potentially important associations between psychological
variables and other phenotypic measures, such as those presented in other manuscripts in
this volume. Instead, cross-domain analyses are presented elsewhere in this volume.6
These limitations notwithstanding, the current findings verify etiologic influences of several
psychological variables that have been implicated as possible risk factors for TMD in
previous cross-sectional studies. The strongest predictors of TMD incidence were measures
of somatic symptoms and their associated latent construct of Global Psychological and
Somatic Symptoms, derived from PCA. In general, these psychological influences were
similar across demographic categories. Future analyses will examine associations of these
psychological variables with transition from acute to chronic pain, and changes in
psychological functioning that accompany onset of TMD will also be explored.
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This article reports that several premorbid psychological variables predict first-onset
TMD in the OPPERA Study, a large prospective cohort study designed to discover causal
determinants of TMD pain. Measures of somatic symptoms were most strongly
associated with TMD onset, but perceived stress, previous life events, and negative affect
also predicted TMD incidence.
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Imputed TMD incidence rates and hazard ratios for stress and negative affectivity for three
levels of Global Psychological and Somatic Symptoms. Each vertical bar depicts the TMD
incidence rate for participants in the bottom (open bar), middle (light gray bar) and upper
(dark gray bar) terciles of “Stress & Negative Affectivity” scores at each tercile (from left to
right) of “Global Psychological and Somatic Symptoms” scores. Incidence rates of first-
onset TMD were computed using multivariable Poisson regression models with multiple
imputation to account for subjects who were not examined as intended. Covariates were
study site (categorical variable, 4 levels), age (in years, with rates estimated for three
selected age groups: 20, 30 and 40 years), race/ethnicity (5 categories – rates not shown for
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"other/unknown" race category) and lifetime US residence (2 categories), Global
Psychological and Somatic Symptoms principal component, Stress and Negative Affectivity
principal component, and the interaction of the two principal components. For the
interaction, p=.0004. Hazard ratios (HR) represent the effect of 1 S.D. increase in the stress
and negative affectivity on TMD incidence. They were calculated using multivariable Cox
regression models with the same covariates described for the Poisson models.
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Partial Dependence Plots for the Pennebaker Inventory of Limbic Languidness (PILL), the
Perceived Stress Scale, and the Coping Strategies Questionnaire (CSQ) Ignoring Pain
Sensations scale. The plots depict the estimated TMD incidence rate that would be observed
at several values of the variable after averaging over the values of all other variables in the
model. TMD incidence rates, expressed as cases per 100-person-years, were generated from
random forest models that predicted TMD onset using study site, demographic variables,
and psychosocial variables presented in Table 1. Predicted values (•) are plotted together
with LOESS-smoothed estimates (- - -) and their 95% confidence intervals (…..). Note that
the y-axis scales vary across the three figures.
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Table 2
Component loadings for Principal Component Analysis (PCA) model
Component 1 Component 2 Component 3 Component 4
KOHN Global Score −0.16 0.23 0.48 −0.28
PILL Global Score 0.42 0.06 0.11 0.07
POMS-Bi Positive Affect 0.15 −0.89 0.09 0.05
POMS-Bi Negative Affect 0.21 0.64 −0.05 0.07
Perceived Stress Scale 0.08 0.72 0.08 0.01
SCL 90R Depression 0.75 0.22 0.01 −0.01
SCL 90R Somatization 0.79 0.03 0.02 0.03
SCL 90R Anxiety 0.92 −0.01 −0.01 −0.03
SCL 90R Obsessive Compulsive 0.80 0.11 −0.03 0.06
SCL 90R Hostility 0.82 −0.01 −0.03 −0.04
SCL 90R Phobia 0.85 −0.13 0.02 −0.06
SCL 90R Paranoid 0.82 −0.03 0.02 0.03
SCL 90R Psychotic 0.86 −0.01 0.02 0.00
CSQ Distraction −0.16 0.01 0.35 0.65
CSQ IgnoringPain 0.06 0.02 −0.33 0.81
CSQ Distancing −0.03 0.12 0.03 0.72
CSQ Coping 0.04 −0.10 −0.01 0.80
CSQ Praying −0.10 −0.08 0.57 0.27
State Anxiety Inventory 0.08 0.81 −0.09 0.00
Trait Anxiety Inventory 0.12 0.78 0.05 0.01
PCS Rumination 0.01 −0.06 0.89 −0.07
PCS Magnification 0.06 −0.01 0.79 0.01
PCS Helplessness 0.06 0.01 0.84 −0.06
EPQ-R Extraversion 0.14 −0.56 0.11 −0.03
EPQ-R Neuroticism 0.11 0.56 0.19 −0.01
PTSD Checklist for Civilians 0.57 −0.06 0.18 −0.01
Cumulative Variance 0.25 0.40 0.51 0.60
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